Lipitor® and Diabetes

LipitorLipitor® was the fifth member of a class of medications known as “statins” that was introduced to the pharmaceutical market in 1997. Lipitor® has been approved by the FDA to be used in conjunction with a healthy diet to lower low-density lipoprotein (bad) cholesterol and blood lipid levels known as triglycerides, with the aim of reducing the risk of cardiovascular disease and stroke. For many years, Lipitor® has been one of the most widely prescribed drugs in America. However, recent studies have shown that women taking Lipitor® may have an increased risk of developing Type 2 diabetes.

Type 2 Diabetes

Type 2 diabetes is a chronic metabolic disorder that causes blood sugar levels to rise without compensation from proper insulin use by the body, otherwise known as “insulin resistance.” The symptoms of Type 2 diabetes include, but are not limited to: increased thirst; increased urination; increased hunger; blurred vision; fatigue; and/or slow healing sores or frequent infections. If left untreated or unmanaged, women with Type 2 diabetes can have very serious complications including:

  • Nerve damage;
  • Kidney failure;
  • Eye damage and vision loss;
  • Increased risk of stroke and/or heart attack;
  • Increased risk of amputation of toes, feet or legs.

If you have concerns that you may have Type 2 diabetes or have already been diagnosed with diabetes and are still taking Lipitor®, please consult with your physician. You should never stop taking any prescription medication without first consulting your physician.

FDA Action

In early 2012, the FDA approved a drug safety update to the label of Lipitor®, and most other statins, informing patients of increased blood sugar levels associated with the drug. This label change was based on clinical studies and adverse events reported in the published medical literature1.

The FDA has also asked for patients who have developed side effects from Lipitor®, including Type 2 diabetes, to report that to the FDA via their website2.

If you are a woman and were diagnosed with Type 2 diabetes while you were taking Lipitor®, you may be entitled to financial compensation.

For more information, please call 1.800.988.8005 or submit a confidential email inquiry (see form above).

Note: Lipitor® is a registered trademark of Pfizer, Inc., and/or its affiliates and is used here for identification only. This law firm is not associated with, sponsored by, endorsed by or affiliated with Pfizer, Inc., or the U.S. Food and Drug Administration. Nothing on this site has been authorized or approved by Pfizer, Inc., or the U.S. Food and Drug Administration.


1 http://www.fda.gov/drugs/drugsafety/ucm293101.htm#pat

2 http://www.accessdata.fda.gov/scripts/medwatch

[ Top of page ]

Share
 

DO I HAVE A CASE? FIND OUT NOW!

Your Name (*) Please let us know your name
Your Phone Number Invalid Input
Your Email Address (*) Please let us know your email address
Type of Case Please select the case type
About the Case (*) Please provide us with case details
Verify the anti-spam code: Verify the anti-spam code:
Invalid code. Please, try again.

NEW YORK OFFICES

new york city800 Third Avenue, 11th Floor
New York, New York 10022
Telephone: 212.605.6200
White Plains NY50 Main Street, Suite 1000
White Plains, New York 10606
Telephone: 914.222.1201
Albany, New York90 State Street
Albany, New York 12207
Telephone: 518.871.1627
Saratoga Springs, New York53 Spring Street, Suite 202
Saratoga Springs, NY 12866
Telephone: 518.871.1627

NEW JERSEY OFFICE

new jersey101 Grovers Mill Rd, Ste 105
Lawrence, New Jersey 08648
Telephone: 609.720.0400

GEORGIA OFFICE

Atlanta, GA1800 Peachtree Street, N.W.
Suite 300
Atlanta, Georgia 30309
Telephone: 404.748.1600

VOTE FOR OUR WEBSITE ON GOOGLE

  If you like our website, let Google know about it by pressing the +1 button. Thank you!
We have 69 guests online